» Articles » PMID: 313405

Subset Derivation of T-cell Acute Lymphoblastic Leukemia in Man

Overview
Journal J Clin Invest
Specialty General Medicine
Date 1979 Aug 1
PMID 313405
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Normal human peripheral blood T cells can be characterized as belonging to either the TH+2 or TH-2 T-cell subset. Approximately 20% of T cells are TH+2, whereas 80% are TH-2 utilizing specific heteroantisera. To determine shether human T-cell acute lymphoblastic leukemia (T-ALL) cells belong to one or another T-cell subset, cell surface phenotyping was performed on tumor populations from 25 patients with T-ALL. Tmuor cells from these 25 individuals were either TH+1 or TH-2, but not both. 5 of 25 patients had TH+2 T-ALL cells. These TH+2 tumor populations were found exclusively in children and often without an accompanying thymic mass. TH-2 T-ALL, in contrast, occurred in both children and adults and was almost always associated with thymic enlargement. Although children with TH+2 T-ALL had as high or higher peripheral blast counts on presentation than their TH-2 T-ALL counterparts, overall survival was greater for the TH+2 group (greater than 36 mo) than the TH-2 group (less than 12 mo). These studies demonstrate that T-cell leukemias in man arise from distinct T-cell subsets and that cell surface characterization of T-cell malignancies may provide useful clinical data related to prognosis.

Citing Articles

Current management of childhood acute lymphocytic leukemia.

Ekert H Indian J Pediatr. 1981; 48(393):491-9.

PMID: 7035349 DOI: 10.1007/BF02822298.


Reactivity of a monoclonal antibody with human ovarian carcinoma.

Bast Jr R, Feeney M, Lazarus H, Nadler L, Colvin R, Knapp R J Clin Invest. 1981; 68(5):1331-7.

PMID: 7028788 PMC: 370929. DOI: 10.1172/jci110380.


Immunologic diagnosis and monitoring of human acute leukemias: a review.

Maheu M, Baker M, Falk J, Taub R Am J Pathol. 1981; 103(1):139-58.

PMID: 7013493 PMC: 1903806.


Childhood acute lymphocytic leukemia: progress and problems in treatment.

Bowman W Can Med Assoc J. 1981; 124(2):129-42.

PMID: 7006781 PMC: 1705168.


The T lymphoblastic malignancies.

Nadler L, Reinherz E, Schlossman S Cancer Chemother Pharmacol. 1980; 4(1):11-5.

PMID: 6988098 DOI: 10.1007/BF00255452.


References
1.
Reinherz E, Schlossman S . Con A-inducible suppression of MLC: evidence for mediation by the TH2 + T cell subset in man. J Immunol. 1979; 122(4):1335-41. View

2.
Lawrence E, Broder S, Jaffe E, Braylan R, Dobbins W, Young R . Evolution of a lymphoma with helper T cell characteristics in Sézary syndrome. Blood. 1978; 52(3):481-92. View

3.
Evans R, Lazarus H, Penta A, Schlossman S . Two functionally distinct subpopulations of human T cells that collaborate in the generation of cytotoxic cells responsible for cell-mediated lympholysis. J Immunol. 1978; 120(4):1423-8. View

4.
Strelkauskas A, Schauf V, Wilson B, Chess L, Schlossman S . Isolation and characterization of naturally occurring subclasses of human peripheral blood T cells with regulatory functions. J Immunol. 1978; 120(4):1278-82. View

5.
Evans R, Breard J, Lazarus H, Schlossman S, Chess L . Detection, isolation, and functional characterization of two human T-cell subclasses bearing unique differentiation antigens. J Exp Med. 1977; 145(1):221-33. PMC: 2180580. DOI: 10.1084/jem.145.1.221. View